Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 1, 2012, Pages 46-55

  Pratheeshkumar, Poyil ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antibody dependent cellular cytotoxicity; Antibody dependent complement mediated cytotoxicity; Cell mediated immunity; Cytokines; Cytotoxic T cells; Natural killer cells; Vernolide A; Vernonia cinerea L.

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; PLANT EXTRACT; UNCLASSIFIED DRUG; VERNOLIDE A; VERNONIA CINEREA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; INTERFERON PRODUCTION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VERNONIA; VERNONIA CINEREA;

ANIMALS; ANTIBODIES, NEOPLASM; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXINS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; SESQUITERPENES; T-LYMPHOCYTES; VERNONIA;

EID: 84055193219     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.574703     Document Type: Article

References (50)

1. Hersh, E., Freireich, E. (1968) Methods in cancer research. New York: Academic Press.
2. Yang, X., Guo, D., Zhang, J., Wu, M. Characterization and antitumor activity of pollen polysaccharide. Int Immunopharmacol 2007, 7, 401-408.
3. Bhattacharyya, N., Pal, A., Patra, S., Haldar, A.K., Roy, S., Ray, M. Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host. Int Immunopharmacol 2008, 8, 1503-1512.
4. Kanagawa, N., Niwa, M., Hatanaka, Y., Tani, Y., Nakagawa, S., Fujita, T., Yamamoto, A., Okada, N. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 2007, 121, 2013-2022. (Pubitemid 47463165)
5. Gao, J.Q., Tsuda, Y., Han, M., Xu, D.H., Kanagawa, N., Hatanaka, Y., Tani, Y., Mizuguchi, H., Tsutsumi, Y., Mayumi, T., Okada, N., Nakagawa, S. NK cells are migrated and indispensable in the antitumor activity induced by CCL27 gene therapy. Cancer Immunol Immunother 2009, 58, 291-299.
6. Leong, S.P. Immunotherapy of malignant melanoma. Surg Clin North Am 1996, 76, 1355-1381. (Pubitemid 27010042)
7. Cooper, M.A., Fehniger, T.A., Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22, 633-640. (Pubitemid 33043908)
8. Robertson, M.J., Ritz, J. Biology and clinical relevance of human natural killer cells. Blood 1990, 76, 2421-2438.
9. Terlikowski, S.J. Local immunotherapy with rhTNF-α mutein induces strong antitumor activity without overt toxicity-a review. Toxicology 2002, 174, 143-152. (Pubitemid 34468023)
10. Misawa, E., Sakurai, T., Yamada, M., Hayasawa, H., Motoyoshi, K. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice. Int J Immunopharmacol 2000, 22, 967-977.
11. Goldsmith, M., Greene, W. (1994). Interleukin-2 and the interleukin-2 receptor complex. Norfolk, England: Paston Press Ltd.
12. Ognibene, F.P., Rosenberg, S.A., Lotze, M., Skibber, J., Parker, M.M., Shelhamer, J.H., Parrillo, J.E. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 1988, 94, 750-754.
13. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., White, D.E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994, 271, 907-913.
14. Billiau, A., Vandenbroeck, K. (2001). Interferon-γ. In Oppenheim, J., Feldmann, M, eds. Cytokine reference. San Diego: Academic Press, 641-688.
15. Fidler, I., Poste, G. (1985). Immunomodulation of macrophages for cancer and antiviral therapy. In Tomlinson, I., Davis, S. eds. Site specific drug delivery. New York: Wiley, 111-135.
16. Agarwal, S., Singh, V. Immunomodulators: A review of studies on Indian medicinal plants and synthetic peptides: Part I. Medicinal Plants 1999, 179-204.
17. Manu, K.A., Kuttan, G. Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 2009, 31, 377-387.
18. Manu, K.A., Kuttan, G. Boerhaavia diffusa stimulates cellmediated immune response by upregulating IL-2 and downregulating the pro-inflammatory cytokines and GM-CSF in B16F-10 metastatic melanoma bearing mice. J Exp Ther Oncol 2008, 7, 17-29. (Pubitemid 351521214)
19. Manu, K.A., Kuttan, G. Effect of Punarnavine, an alkaloid from Boerhaavia diffusa, on cell-mediated immune responses and TIMP-1 in B16F-10 metastatic melanoma-bearing mice. Immunopharmacol Immunotoxicol 2007, 29, 569-586. (Pubitemid 350261183)
20. Sheeja, K., Kuttan, G. Andrographis paniculata downregulates proinflammatory cytokine production and augments cell mediated immune response in metastatic tumor-bearing mice. Asian Pac J Cancer Prev 2010, 11, 723-729.
21. Sheeja, K., Kuttan, G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol 2007, 29, 81-93. (Pubitemid 46676489)
22. Sheeja, K., Kuttan, G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther 2007, 6, 66-73.
23. Kumar, P.P., Kuttan, G. Vernonia cinerea L. scavenges free radicals and regulates nitric oxide and proinflammatory cytokines profile in carrageenan induced paw edema model. Immunopharmacol Immunotoxicol 2009, 31, 94-102.
24. Pratheeshkumar, P., Kuttan, G. Modulation of immune response by Vernonia cinerea L. inhibits the proinflammatory cytokine profile, iNOS, and COX-2 expression in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol 2010, 1-11.
25. Pratheeshkumar, P., Kuttan, G. Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice. Inflammopharmacology 2010, 1-11.
26. Pratheeshkumar, P., Kuttan, G. Vernonia cinerea Less. Inhibits Tumor Cell Invasion and Pulmonary Metastasis in C57BL/6 Mice. Integr Cancer Ther 2010.
27. Kuo, Y.H., Kuo, Y.J., Yu, A.S., Wu, M.D., Ong, C.W., Yang Kuo, L.M., Huang, J.T., Chen, C.F., Li, S.Y. Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea. Chem Pharm Bull 2003, 51, 425-426.
28. Chea, A., Hout, S., Long, C., Marcourt, L., Faure, R., Azas, N., Elias, R. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem Pharm Bull 2006, 54, 1437-1439. (Pubitemid 44506579)
29. Chen, X., Zhan, Z.J., Yue, J.M. Sesquiterpenoids from Vernonia cinerea. Nat Prod Res 2006, 20, 31-35. (Pubitemid 41823596)
30. Kim, Y.B., Huh, N.D., Koren, H.S., Amos, D.B. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J Immunol 1980, 125, 755-762. (Pubitemid 10045656)
31. Gupta, S., Bhattacharya, B. (1983). Cytotoxicity assays. In Talwar, G.P., ed. A handbook of practical immunology. New Delhi: Vikas Publishing House, 328-333.
32. Kobayashi, H., Aso, H., Ishida, N., Maeda, H., Schmitt, D.A., Pollard, R.B., Suzuki, F. Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes. Immunopharmacol Immunotoxicol 1992, 14, 841-864. (Pubitemid 23000955)
33. Manesh, C., Kuttan, G. Effect of naturally occurring isothiocyanates on the immune system. Immunopharmacol Immunotoxicol 2003, 25, 451-459. (Pubitemid 37204454)
34. Kempf, R.A., Mitchell, M.S. Effects of chemotherapeutic agents on the immune response. II. Cancer Invest 1985, 3, 23-33. (Pubitemid 15149963)
35. Santin, A.D., Hermonat, P.L., Ravaggi, A., Bellone, S., Roman, J., Pecorelli, S., Cannon, M., Parham, G.P. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 2000, 48, 997-1006.
36. Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 2002, 87, 21-27.
37. Gross, S., Walden, P. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol Lett 2008, 116, 7-14.
38. Kim, K.D., Choi, S.C., Kim, A., Choe, Y.K., Choe, I.S., Lim, J.S. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction. Int Immunopharmacol 2001, 1, 2117-2129. (Pubitemid 32973704)
39. Shan, Y., Sugiura, Y. Suppressive effect of Chinese medicinal herb, Acanthopanax gracilistylus, extract on human lymphocytes in vitro. Clin Exp Immunol 1999, 118, 41-48.
40. Ahmad, A., Menezes, J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J 1996, 10, 258-266. (Pubitemid 26079945)
41. Boon, T., Coulie, P.G., Van den Eynde, B.J., van der Bruggen, P. Human T cell responses against melanoma. Annu Rev Immunol 2006, 24, 175-208.
42. Zitvogel, L., Tesniere, A., Kroemer, G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006, 6, 715-727. (Pubitemid 44453458)
43. Farrar, W.L., Mizel, S.B., Farrar, J.J. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol 1980, 124, 1371-1377. (Pubitemid 10062812)
44. Siegel, J.P. Effects of interferon-gamma on the activation of human T lymphocytes. Cell Immunol 1988, 111, 461-472. (Pubitemid 18061830)
45. GORER, P.A. Studies in antibody response of mice to tumour inoculation. Br J Cancer 1950, 4, 372-379.
46. Win, S., Uenaka, A., Nakayama, E. Immune responses against allogeneic and syngeneic tumors in aged C57BL/6 mice. Microbiol Immunol 2002, 46, 513-519. (Pubitemid 34831217)
47. Asano, Y., Kaneda, K., Hiragushi, J., Tsuchida, T., Higashino, K. The tumor-bearing state induces augmented responses of organassociated lymphocytes to high-dose interleukin-2 therapy in mice. Cancer Immunol Immunother 1997, 45, 63-70. (Pubitemid 27497680)
48. Caligiuri, M.A., Murray, C., Robertson, M.J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M.E., Klumpp, T.R., Soiffer, R.J. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest 1993, 91, 123-132. (Pubitemid 23037263)
49. Henney, C., Kuribayashi, K., Kern, D., Gillis, S. Interleukin-2 augments natural killer cell activity. Nature 1981, 291, 335-338. (Pubitemid 11083437)
50. Ehrhardt, R.O., Ludvíksson, B.R., Gray, B., Neurath, M., Strober, W. Induction and prevention of colonic inflammation in IL-2- deficient mice. J Immunol 1997, 158, 566-573. (Pubitemid 127492631)